06.02.26 -- Why Are Life Science Companies So Poorly Prepared For RIM's Future?

Regulators are implementing new rules to combat counterfeit medicines. Learn how serialization, tamper-evident seals, and track-and-trace solutions protect products and patients from risk.

Move beyond relative quantification to achieve absolute precision. Find out how partitioning technology overcomes qPCR limitations to deliver reproducible gene expression data for rare targets.

Global recalls demand more than fast action. See how differing requirements, documentation standards, and timelines shape recall outcomes, and why preparedness is critical to avoiding regulatory risk.

Blow/Fill/Seal technology supports contamination control, reduces operator risk, and meets sterility assurance requirements under dynamic conditions with advanced airflow and monitoring.

Multi-lane checkweighing boosts operational efficiency, ensures accurate dosing, and simplifies changeovers, making it ideal for applications like dual-chamber sachets and nutraceutical products.

Uncover how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

Reconstituted nasal epithelium (RNE) offers a human-relevant model for nasal drug delivery, outperforming frozen mucosa and aligning better with clinical outcomes for opioid formulations.

As biopharma shifts toward personalized and smaller‑batch therapies, modular infrastructure is redefining how facilities are built and scaled to enable faster deployment and greater flexibility.

Traditional MES platforms were built for stable environments that no longer exist. Manufacturers are now adopting composable execution architectures to reduce friction and adapt faster.

Explore strategies for accommodating the ever-increasing upstream titers and volumes to prevent downstream purification from becoming a bottleneck.

Gain insight into a family of medical-grade polyurethanes that are engineered for high performance, biocompatibility, and reliability in advanced, critical medical device applications.

Biologics manufacturing is evolving through smarter fill technologies, onshoring, advanced automation, and data driven processes that improve efficiency, reduce risk, and protect product value.